A successful treatment of life-threatening bleeding from polycystic kidneys with antifibrinolytic agent tranexamic acid

Blood Coagulation and Fibrinolysis

Volumn 17, Issue 7, 2006, Pages 589-591

  Vujkovac, Bojan ^a   Sabovic, Miso ^b  

^a General Hospital Celje   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Autosomal dominant polycystic kidney disease; Fibrinolysis; Haematuria; Tranexamic acid

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ANTIFIBRINOLYTIC AGENT; COLLAGEN; D DIMER; FIBRINOGEN; FRESH FROZEN PLASMA; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN; TRANEXAMIC ACID; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BED REST; BLEEDING TIME; BLOOD CLOT; BLOOD TRANSFUSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; ERYTHROCYTE CONCENTRATE; EUGLOBULIN LYSIS TEST; FIBRINOLYSIS; FLUID RESUSCITATION; FOLLOW UP; HEMATURIA; HUMAN; KIDNEY FAILURE; KIDNEY HEMORRHAGE; KIDNEY POLYCYSTIC DISEASE; MALE; NEPHRECTOMY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE COUNT; URETER CATHETER; URETER OBSTRUCTION;

ANTIFIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEMATURIA; HUMANS; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY DISEASES; TOMOGRAPHY, X-RAY COMPUTED; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 33748947891     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000245293.41774.c8     Document Type: Article

References (16)

1. Gabow PA, Duley I, Johnson AM. Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1992; 20:140-143.
2. Andersson L, Eriksson O, Hedlund PO, Kjelmann H, Lindqvist B. Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases. Urol Res 1978; 6:83-88.
3. Mannucci PM. Hemostatic drugs. N Engl J Med 1998; 339:245-253.
4. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999; 57:1005-1032.
5. Levy JH. Pharmacologic preservatiotion of the hemostatic system during cardiac surgery. Ann Thorac Surg 2001; 72:S1814-S1820.
6. Wellington K, Wagstaff AJ. Tranexamic acid: a review of its use in the management of menorrhagia. Drugs 2003; 63:1417-1433.
7. Zwettler U, Zeier M, Andrassy K, Geberth S, Rambausek M. Treatment of gross hematuria in autosomal dominant polycistic kidney disease with aprotinin and desmopressin acetate [letter]. Nephron 1992; 60:374.
8. Mezzano D, Panes O, Munoz B, Pais E, Tagle R, Gonzales F, et al. Tranexamic acid inhibits fibrinolysis, shortens the bleeding time and improves platelet function in patients with chronic renal failure. Thromb Haemost 1999; 82:1250-1254.
9. Mezzano D, Munoz B, Pais E, Downey P, Pereira J. Fast decrease of bleeding time by tranexamic acid in uremia [letter]. Thromb Haemost 2000; 83:785.
10. Sabovic M, Preloznik Zupan I, Salobir B, Zupan I, Cernelc P, Lavre J, et al. The effect of long term, low-dose tranexamic acid treatment on platelet dysfunction and haemoglobin levels in haemodialysis patients. Thromb Haemost 2005; 94:1245-1250.
11. Vujkovac B, Lavre J, Sabovic M. Successful treatment of bleeding from colonic angiodysplasias with tranexamic acid in a hemodialysis patient. Am J Kidney Dis 1998; 31:536-538.
12. Vujkovac B, Sabovic M. Treatment of subdural and intracerebral hematomas in a haemodialysis patient with tranexamic acid. Nephrol Dial Transplant 2000; 15:107-109.
13. Sabovic M, Lavre J, Vujkovac B. Tranexamic acid is effective as adjunctive therapy in treating major upper gastrointestinal bleeding in dialysis patients. Nephrol Dial Transplant 2003; 18:1-4.
14. Lindoff C, Rybo G, Asted B. Treatment with tranexamic acid during pregnancy and the risk of thrombembolic complications. Thromb Haemost 1993; 70:238-240.
15. Rao KV. Use of epsilon aminocaproic acid in protracted bleeding from polycystic kidneys: a case report. J Urol 1986; 136:887-888.
16. Luddington RJ. Thrombelastography/thrombelastometry. Clin Lab Haematol 2005; 27:81-90.